← Back to all trials
Completed
NCT06641921
Strategy TO Prevent Decompensated Heart Failure
Conditions: Heart Failure, Remote Monitoring
Sex: All
Ages: 18 Years – 100 Years
Healthy volunteers: No
Phase: NA
Enrollment: 330
Sponsor: Seerlinq s. r. o.
Location: Premedix Clinic Bratislava Nové Mesto
Summary
The goal of this prospective, multicenter, single-arm, open-label clinical trial (Strategy TO Prevent Decompensated Heart Failure) is to evaluate the 12-month incidence of heart failure hospitalization (HFH) and all cause mortality in patients managed with haemodynamically guided treatment using the Seerlinq telemedical monitoring system.
Eligibility Criteria
Inclusion Criteria
1. Males and females aged ≥ 18 years.
2. Able to understand, and willing to provide written informed consent.
3. Stated willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study.
4. Diagnosis of chronic heart failure in NYHA class II or III
5. Able to stand for 2 minutes
6. Access to necessary resources for participating in a technology-based intervention (smartphone, blood pressure monitor, internet access).
Exclusion Criteria
The participant may not enter the study if ANY of the following apply:
1. Use of other services for telemedical monitoring for heart failure.
2. Renal failure with a Glomerular Filtration Rate (GFR) \
Source: ClinicalTrials.gov (NCT06641921). StuddyBuddy aggregates publicly available trial information.
